Please Wait

Applying Filters...

Looking for Psorcutan? Find Coating Systems & Additives used in Psorcutan to address drug delivery challenges on PharmaCompass.

Psorcutan

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

45 API Suppliers, 17 USDMF, 11 CEP/COS, 4 EU WC, 1 KDMF, 12 NDC API, 21 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

64 Drugs in Development

64 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

256 FDF Dossiers, 23 FDA Orange Book, 189 Europe, 23 Canada, 8 Australia, 8 South Africa, 5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.005%, SOLUTION;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;TOPICAL - 0.064%;0.005%, SUSPENSION;TOPICAL - 0.064%;0.005%, AEROSOL, FOAM;TOPICAL - 0.005%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 DKSH, 4 Nanjing Well Pharmaceutical, 4 Kirsch Pharma, 3 Actylis, 12 BASF, 1 Corel Pharma Chem, 2 Finar, 1 Pluviaendo, 1 Seppic, 1 Symrise, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

20 Topical, 10 Parenteral, 7 Solubilizers, 5 Thickeners and Stabilizers, 4 Film Formers & Plasticizers, 4 Emulsifying Agents, 3 Lubricants & Glidants, 2 Granulation, 2 Direct Compression, 1 Fillers, Diluents & Binders, 1 Surfactant & Foaming Agents, 1 Controlled & Modified Release

DIGITAL CONTENT

29 News #PharmaBuzz

29 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions, 43 Regulatory FDF Prices, 12 Annual Reports

MARKET PLACE

10 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

18 US Patents, 6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 Others

$ Xls

Filters

Psorcutan

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for Psorcutan? Find Coating Systems & Additives used in Psorcutan to address drug delivery challenges on PharmaCompass.

Psorcutan

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

45 API Suppliers

17 USDMF

11 CEP/COS

4 EU WC

1 KDMF

12 NDC API

21 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

64 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

256 FDF Dossiers

23 FDA Orange Book

189 Europe

23 Canada

8 Australia

8 South Africa

5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.005%

SOLUTION;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

OINTMENT;TOPICAL - 0.064%;0.005%

SUSPENSION;TOPICAL - 0.064%;0.005%

AEROSOL, FOAM;TOPICAL - 0.005%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 DKSH

4 Nanjing Well Pharmaceutical

4 Kirsch Pharma

3 Actylis

12 BASF

1 Corel Pharma Chem

2 Finar

1 Pluviaendo

1 Seppic

1 Symrise

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

20 Topical

10 Parenteral

7 Solubilizers

5 Thickeners and Stabilizers

4 Film Formers & Plasticizers

4 Emulsifying Agents

3 Lubricants & Glidants

2 Granulation

2 Direct Compression

1 Fillers, Diluents & Binders

1 Surfactant & Foaming Agents

1 Controlled & Modified Release

DIGITAL CONTENT

29 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions

43 Regulatory FDF Prices

12 Annual Reports

MARKET PLACE

10 APIs

1 FDF Dossiers

PATENTS & EXCLUSIVITIES

18 US Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM

1 Others

Filters

Psorcutan

SOLUTION;TOPICAL - 0.005% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons